Report of Foreign Issuer (6-k)
February 22 2019 - 4:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of February 2019
Commission File Number:
001-36697
DBV TECHNOLOGIES S.A.
(Translation of registrants name into English)
177-181
avenue Pierre Brossolette
92120 Montrouge France
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F:
☒ Form
20-F ☐ Form
40-F
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7): ☐
EXPLANATORY NOTE
On February 22, 2019, DBV Technologies S.A. announced that detailed results from its pivotal Phase III clinical trial evaluating the efficacy and safety
of Viaskin Peanut for the treatment of peanut-allergic children 4 to 11 years of age were published in The Journal of the American Medical Association (JAMA). DBV Technologies S.A. prepared a presentation in connection with the results
published in JAMA, which it intends to use in conferences and meetings with investors. Copies of the press release and the presentation are filed with this Report of Foreign Private Issuer on Form
6-K
as
Exhibits 99.1 and 99.2, respectively, and are incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
DBV TECHNOLOGIES S.A.
|
|
|
|
Date: February 22, 2019
|
|
By:
|
|
/s/ David Schilansky
|
|
|
Name:
|
|
David Schilansky
|
|
|
Title:
|
|
Deputy Chief Executive Officer
|
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From Mar 2024 to Apr 2024
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From Apr 2023 to Apr 2024